BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 32511971)

  • 1. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19.
    Bao J; Li C; Zhang K; Kang H; Chen W; Gu B
    Clin Chim Acta; 2020 Oct; 509():180-194. PubMed ID: 32511971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
    Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of organ function in patients with severe COVID-19 infections.
    Zhu Y; Du Z; Zhu Y; Li W; Miao H; Li Z
    Med Clin (Barc); 2020 Sep; 155(5):191-196. PubMed ID: 32586669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case-control study.
    Ke C; Yu C; Yue D; Zeng X; Hu Z; Yang C
    Med Clin (Barc); 2020 Oct; 155(8):327-334. PubMed ID: 32782109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.
    Henry BM; Benoit SW; de Oliveira MHS; Hsieh WC; Benoit J; Ballout RA; Plebani M; Lippi G
    Clin Biochem; 2020 Jul; 81():1-8. PubMed ID: 32473151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic changes in routine blood parameters of a severe COVID-19 case.
    Lu G; Wang J
    Clin Chim Acta; 2020 Sep; 508():98-102. PubMed ID: 32405079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis.
    Deng X; Liu B; Li J; Zhang J; Zhao Y; Xu K
    Clin Chem Lab Med; 2020 Jul; 58(8):1172-1181. PubMed ID: 32554832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of SAA, CRP, and FERR in different severities of COVID-19.
    Liu SL; Wang SY; Sun YF; Jia QY; Yang CL; Cai PJ; Li JY; Wang L; Chen Y
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11386-11394. PubMed ID: 33215460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis.
    Soraya GV; Ulhaq ZS
    Med Clin (Barc); 2020 Aug; 155(4):143-151. PubMed ID: 32586670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.
    Bonetti G; Manelli F; Patroni A; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Anesi A; Lippi G
    Clin Chem Lab Med; 2020 Jun; 58(7):1100-1105. PubMed ID: 32573995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience.
    Sun Y; Dong Y; Wang L; Xie H; Li B; Chang C; Wang FS
    J Autoimmun; 2020 Aug; 112():102473. PubMed ID: 32439209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory Tests and Outcome for Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Alnor A; Sandberg MB; Gils C; Vinholt PJ
    J Appl Lab Med; 2020 Sep; 5(5):1038-1049. PubMed ID: 32573713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging key laboratory tests for patients with COVID-19.
    Kavsak PA; de Wit K; Worster A
    Clin Biochem; 2020 Jul; 81():13-14. PubMed ID: 32360478
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.
    Li H; Xiang X; Ren H; Xu L; Zhao L; Chen X; Long H; Wang Q; Wu Q
    J Infect; 2020 Jun; 80(6):646-655. PubMed ID: 32277967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.